{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T16:30:08Z","timestamp":1745253008740,"version":"3.37.3"},"reference-count":29,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"MOST","doi-asserted-by":"publisher","award":["NSC 100-2314-B-039-031","MOST 107-2320-B-039-032-MY3"],"award-info":[{"award-number":["NSC 100-2314-B-039-031","MOST 107-2320-B-039-032-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU103-S-20"],"award-info":[{"award-number":["CMU103-S-20"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Health and welfare surcharge of tobacco products","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Medical University Hospital Cancer Research Center of Excellence","award":["MOHW108-TDU-B-212-124024"],"award-info":[{"award-number":["MOHW108-TDU-B-212-124024"]}]}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jfda.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T13:30:03Z","timestamp":1571405403000},"page":"183-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Involvement of prohibitin 1 and prohibitin 2 upregulation in cBSA-induced podocyte cytotoxicity"],"prefix":"10.38212","volume":"28","author":[{"given":"Heng-Hsiung","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-9243","authenticated-orcid":false,"given":"Chao-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Huei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2019.09.003_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MAJ.0b013e318223e800","article-title":"Urothelial carcinoma in patients with advanced kidney disease: a 12-year retrospective cohort survey","volume":"342","author":"Hung","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jfda.2019.09.003_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2010.01.008","article-title":"The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey","volume":"56","author":"Glassock","year":"2010","journal-title":"Am J Kidney Dis : Off J Natl Kidney Found"},{"key":"10.1016\/j.jfda.2019.09.003_bib3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","article-title":"Early-childhood membranous nephropathy due to cationic bovine serum albumin","volume":"364","author":"Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa012895","article-title":"Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies","volume":"346","author":"Debiec","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol : JASN"},{"key":"10.1016\/j.jfda.2019.09.003_bib7","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2215\/CJN.03850414","article-title":"M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy","volume":"9","author":"Hoxha","year":"2014","journal-title":"Clin J Am Soc Nephrol : CJASN"},{"key":"10.1016\/j.jfda.2019.09.003_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfda.2019.09.003_bib9","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jfda.2019.09.003_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMc1500130","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"372","author":"Godel","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib11","first-page":"1074","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"372","author":"Meyer-Schwesinger","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib12","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib13","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1093\/ndt\/gfh419","article-title":"Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences","volume":"19","author":"Chen","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jfda.2019.09.003_bib14","first-page":"135","article-title":"Mouse models of membranous nephropathy: the road less travelled by","volume":"2","author":"Borza","year":"2013","journal-title":"Afr J Clin Exp Immunol"},{"key":"10.1016\/j.jfda.2019.09.003_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: recent advances and future challenges","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jfda.2019.09.003_bib16","article-title":"Urethral dysfunction in female mice with estrogen receptor beta deficiency","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jfda.2019.09.003_bib17","doi-asserted-by":"crossref","first-page":"41437","DOI":"10.1038\/srep41437","article-title":"Aqueous extract of Polygonum bistorta modulates proteostasis by ROS-induced ER stress in human hepatoma cells","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfda.2019.09.003_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phymed.2018.03.037","article-title":"Aqueous extracts of Paeonia suffruticosa modulates mitochondrial proteostasis by reactive oxygen species-induced endoplasmic reticulum stress in pancreatic cancer cells","volume":"46","author":"Liu","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jfda.2019.09.003_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.jfda.2019.09.003_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MNH.0b013e3282f2904d","article-title":"The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?","volume":"17","author":"Reddy","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jfda.2019.09.003_bib21","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2174\/138161207781662957","article-title":"The podocyte: a potential therapeutic target in diabetic nephropathy?","volume":"13","author":"Marshall","year":"2007","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.jfda.2019.09.003_bib22","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1038\/sj.ki.5002384","article-title":"Podocyte biology in diabetic nephropathy","author":"Li","year":"2007","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jfda.2019.09.003_bib23","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10495-015-1143-z","article-title":"Multifaceted role of prohibitin in cell survival and apoptosis","volume":"20","author":"Peng","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.jfda.2019.09.003_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.chembiol.2013.02.006","article-title":"Prohibitin ligands in cell death and survival: mode of action and therapeutic potential","volume":"20","author":"Thuaud","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.jfda.2019.09.003_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nature08466","article-title":"Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C. elegans","volume":"461","author":"Artal-Sanz","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jfda.2019.09.003_bib26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s12035-016-0328-y","article-title":"Low levels of prohibitin in substantia nigra makes dopaminergic neurons vulnerable in Parkinson's disease","volume":"55","author":"Dutta","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jfda.2019.09.003_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.15252\/emmm.201404916","article-title":"Inhibition of insulin\/IGF-1 receptor signaling protects from mitochondria-mediated kidney failure","volume":"7","author":"Ising","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jfda.2019.09.003_bib28","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/MCB.25.5.1989-1999.2005","article-title":"Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in\u00a0vivo","volume":"25","author":"Park","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jfda.2019.09.003_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010071","article-title":"Prohibitins: a critical role in mitochondrial functions and implication in diseases","volume":"8","author":"Signorile","year":"2019","journal-title":"Cells"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949819300870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949819300870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949819300870?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:20:09Z","timestamp":1666635609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1021949819300870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1021949819300870"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2019.09.003","relation":{},"ISSN":["1021-9498"],"issn-type":[{"type":"print","value":"1021-9498"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of prohibitin 1 and prohibitin 2 upregulation in cBSA-induced podocyte cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}